| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 5.05e-07 | 14 | 97 | 4 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 4.32e-06 | 23 | 97 | 4 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 1.13e-05 | 29 | 97 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.13e-05 | 29 | 97 | 4 | GO:0035325 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 2.17e-05 | 34 | 97 | 4 | GO:0015125 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 2.30e-05 | 70 | 97 | 5 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 2.82e-05 | 73 | 97 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | glycolipid binding | 9.38e-05 | 49 | 97 | 4 | GO:0051861 | |
| GeneOntologyMolecularFunction | stalled ribosome sensor activity | 1.39e-04 | 4 | 97 | 2 | GO:0170011 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 3.90e-04 | 196 | 97 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | SUPT20HL1 BCL9L SUPT20H CMTM2 HIPK2 SUPT20HL2 TRRAP JMJD1C MED15 NPAT | 4.03e-04 | 562 | 97 | 10 | GO:0003712 |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 8.03e-04 | 149 | 97 | 5 | GO:1990782 | |
| GeneOntologyMolecularFunction | calmodulin binding | 9.04e-04 | 230 | 97 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 9.71e-04 | 90 | 97 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 1.02e-03 | 324 | 97 | 7 | GO:0005126 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 6.00e-09 | 15 | 97 | 5 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 6.00e-09 | 15 | 97 | 5 | GO:0002859 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 3.97e-08 | 21 | 97 | 5 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 3.97e-08 | 21 | 97 | 5 | GO:0002838 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 6.52e-08 | 23 | 97 | 5 | GO:0002858 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 8.21e-08 | 24 | 97 | 5 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 8.21e-08 | 24 | 97 | 5 | GO:0002420 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 1.02e-07 | 25 | 97 | 5 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of small molecule metabolic process | CACNA1A SUPT20HL1 SUPT20H PSG2 PSG4 PSG6 PDK2 CMTM2 SUPT20HL2 H6PD EPM2AIP1 PSG8 PROX1 | 1.24e-07 | 434 | 97 | 13 | GO:0062012 |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 3.77e-07 | 32 | 97 | 5 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 4.44e-07 | 14 | 97 | 4 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 6.03e-07 | 15 | 97 | 4 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 6.03e-07 | 15 | 97 | 4 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 8.01e-07 | 16 | 97 | 4 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.04e-06 | 17 | 97 | 4 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.04e-06 | 17 | 97 | 4 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.04e-06 | 17 | 97 | 4 | GO:0038158 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.20e-06 | 40 | 97 | 5 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell proliferation | 1.20e-06 | 226 | 97 | 9 | GO:0050680 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 1.34e-06 | 18 | 97 | 4 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.36e-06 | 41 | 97 | 5 | GO:0002716 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 2.10e-06 | 20 | 97 | 4 | GO:2000346 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 2.44e-06 | 46 | 97 | 5 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 2.44e-06 | 46 | 97 | 5 | GO:0072574 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 2.59e-06 | 21 | 97 | 4 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 2.61e-06 | 83 | 97 | 6 | GO:0002707 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 2.72e-06 | 47 | 97 | 5 | GO:0001911 | |
| GeneOntologyBiologicalProcess | regulation of ketone metabolic process | 3.09e-06 | 189 | 97 | 8 | GO:0010565 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 3.15e-06 | 22 | 97 | 4 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 3.21e-06 | 86 | 97 | 6 | GO:0042058 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 3.36e-06 | 49 | 97 | 5 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 3.36e-06 | 49 | 97 | 5 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 3.71e-06 | 50 | 97 | 5 | GO:0002834 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 3.80e-06 | 23 | 97 | 4 | GO:0090331 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 4.52e-06 | 52 | 97 | 5 | GO:0031342 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 4.54e-06 | 24 | 97 | 4 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 5.07e-06 | 93 | 97 | 6 | GO:1901184 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 5.39e-06 | 25 | 97 | 4 | GO:0035726 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 6.10e-06 | 96 | 97 | 6 | GO:0002704 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 6.55e-06 | 56 | 97 | 5 | GO:0002418 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 7.42e-06 | 27 | 97 | 4 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 8.63e-06 | 28 | 97 | 4 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 9.97e-06 | 29 | 97 | 4 | GO:2001212 | |
| GeneOntologyBiologicalProcess | cellular response to peptide hormone stimulus | 1.24e-05 | 381 | 97 | 10 | GO:0071375 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.31e-05 | 31 | 97 | 4 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.49e-05 | 32 | 97 | 4 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 1.49e-05 | 32 | 97 | 4 | GO:0070341 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye morphogenesis | 1.49e-05 | 32 | 97 | 4 | GO:0048596 | |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | SUPT20HL1 SUPT20H PSG2 PSG4 PSG6 PDK2 CMTM2 SUPT20HL2 H6PD PSG8 SLC25A19 HTT PROX1 | 1.67e-05 | 676 | 97 | 13 | GO:0044283 |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 1.69e-05 | 33 | 97 | 4 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 1.69e-05 | 33 | 97 | 4 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 1.91e-05 | 34 | 97 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 1.91e-05 | 34 | 97 | 4 | GO:0046851 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 2.11e-05 | 71 | 97 | 5 | GO:0043114 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 2.11e-05 | 71 | 97 | 5 | GO:0002347 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 2.15e-05 | 35 | 97 | 4 | GO:1901142 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 2.89e-05 | 126 | 97 | 6 | GO:1903035 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 2.94e-05 | 76 | 97 | 5 | GO:0042269 | |
| GeneOntologyBiologicalProcess | embryonic eye morphogenesis | 3.00e-05 | 38 | 97 | 4 | GO:0048048 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 3.00e-05 | 38 | 97 | 4 | GO:2000345 | |
| GeneOntologyBiologicalProcess | regulation of tissue remodeling | 3.16e-05 | 128 | 97 | 6 | GO:0034103 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 3.33e-05 | 39 | 97 | 4 | GO:0045717 | |
| GeneOntologyBiologicalProcess | response to insulin | 3.38e-05 | 342 | 97 | 9 | GO:0032868 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | BCL9L PSG2 PSG4 PSG6 PDK2 RBM4 HIPK2 TGFB1 KIAA0319 PTPN12 PELO GUCY2C FURIN OSBPL8 PSG8 FGFR3 SOS2 | 3.50e-05 | 1186 | 97 | 17 | GO:0007167 |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 3.76e-05 | 132 | 97 | 6 | GO:0043255 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 3.77e-05 | 80 | 97 | 5 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 3.77e-05 | 80 | 97 | 5 | GO:0046850 | |
| GeneOntologyBiologicalProcess | response to peptide hormone | PSG2 PSG4 PSG6 PDK2 RBM4 NR4A2 EPM2AIP1 TGFB1 OSBPL8 PSG8 SOS2 | 3.94e-05 | 530 | 97 | 11 | GO:0043434 |
| GeneOntologyBiologicalProcess | negative regulation of cell population proliferation | PSG2 PSG4 PSG6 IFT172 SAV1 MUC16 RFPL1 IFNA2 IFNA5 TGFB1 CHD5 PSG8 FGFR3 VGLL4 PROX1 | 4.10e-05 | 961 | 97 | 15 | GO:0008285 |
| GeneOntologyBiologicalProcess | cellular response to insulin stimulus | 4.22e-05 | 271 | 97 | 8 | GO:0032869 | |
| GeneOntologyBiologicalProcess | negative regulation of cell development | 4.33e-05 | 353 | 97 | 9 | GO:0010721 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 4.49e-05 | 42 | 97 | 4 | GO:0090330 | |
| GeneOntologyBiologicalProcess | epithelium development | PSG2 PSG4 PSG6 RBM4 IFT172 SAV1 JMJD1C RYR2 TGFB1 C2CD3 PELO PSG8 FGFR3 KAZN STRA6 CPLANE1 USH2A HTT PROX1 | 4.66e-05 | 1469 | 97 | 19 | GO:0060429 |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 5.02e-05 | 139 | 97 | 6 | GO:0007173 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | CACNA1A PSG2 PSG4 PSG6 PDK2 RBM4 NR4A2 RYR2 TGFB1 OSBPL8 PSG8 HTT SOS2 | 5.03e-05 | 752 | 97 | 13 | GO:1901699 |
| GeneOntologyBiologicalProcess | ketone metabolic process | 5.18e-05 | 279 | 97 | 8 | GO:0042180 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 5.65e-05 | 87 | 97 | 5 | GO:0001974 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 5.91e-05 | 45 | 97 | 4 | GO:0048521 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye development | 5.91e-05 | 45 | 97 | 4 | GO:0031076 | |
| GeneOntologyBiologicalProcess | protein catabolic process | FBXL13 PSG2 PSG4 PSG6 HIPK2 HUWE1 RFPL1 ARAF BNIP3 SH3RF2 FURIN PSG8 VGLL4 FBXO21 CLEC16A PRAME | 6.05e-05 | 1115 | 97 | 16 | GO:0030163 |
| GeneOntologyBiologicalProcess | negative regulation of neuroblast proliferation | 6.54e-05 | 17 | 97 | 3 | GO:0007406 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 7.00e-05 | 91 | 97 | 5 | GO:0051055 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 7.02e-05 | 47 | 97 | 4 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 7.02e-05 | 47 | 97 | 4 | GO:0034104 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | CACNA1A PSG2 PSG4 PSG6 PDK2 RBM4 NR4A2 IFNA2 IFNA5 RYR2 EPM2AIP1 TGFB1 OSBPL8 PSG8 MTARC2 HTT SOS2 | 8.35e-05 | 1272 | 97 | 17 | GO:1901698 |
| GeneOntologyBiologicalProcess | head development | CACNA1A IFT172 NR4A2 TGFB1 GDPD5 C2CD3 BNIP3 CELSR2 CHD5 FGFR3 STRA6 CPLANE1 HTT PROX1 | 9.83e-05 | 919 | 97 | 14 | GO:0060322 |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 9.97e-05 | 98 | 97 | 5 | GO:0061045 | |
| GeneOntologyBiologicalProcess | lymphocyte proliferation | 1.08e-04 | 398 | 97 | 9 | GO:0046651 | |
| GeneOntologyBiologicalProcess | ERBB signaling pathway | 1.10e-04 | 160 | 97 | 6 | GO:0038127 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 1.13e-04 | 53 | 97 | 4 | GO:0034110 | |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 1.13e-04 | 161 | 97 | 6 | GO:0003231 | |
| GeneOntologyBiologicalProcess | osteoclast differentiation | 1.17e-04 | 162 | 97 | 6 | GO:0030316 | |
| GeneOntologyBiologicalProcess | mononuclear cell proliferation | 1.26e-04 | 406 | 97 | 9 | GO:0032943 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | SUPT20HL1 SUPT20H IFT172 HIPK2 SUPT20HL2 RYR2 TGFB1 C2CD3 STRA6 CPLANE1 HTT PROX1 | 1.29e-04 | 713 | 97 | 12 | GO:0048598 |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 1.29e-04 | 237 | 97 | 7 | GO:0019827 | |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | 1.34e-04 | 166 | 97 | 6 | GO:0002698 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response | 1.36e-04 | 239 | 97 | 7 | GO:0050777 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | PSG2 PSG4 PSG6 RBM4 ARHGEF5 HIPK2 HUWE1 RFPL1 IFNA2 ARAF IFNA5 TGFB1 SH3RF2 FURIN PSG8 FGFR3 VGLL4 PROX1 | 1.38e-04 | 1458 | 97 | 18 | GO:0051247 |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 1.38e-04 | 105 | 97 | 5 | GO:0042267 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 1.47e-04 | 242 | 97 | 7 | GO:0098727 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 9.67e-07 | 16 | 103 | 4 | GO:0070021 | |
| GeneOntologyCellularComponent | SAGA complex | 6.49e-06 | 25 | 103 | 4 | GO:0000124 | |
| GeneOntologyCellularComponent | SAGA-type complex | 4.00e-05 | 39 | 103 | 4 | GO:0070461 | |
| GeneOntologyCellularComponent | transcription regulator complex | BCL9L RBL1 NR4A2 HIPK2 MLXIP TRRAP GATAD2B MED15 GTF3C1 CHD5 | 7.20e-04 | 596 | 103 | 10 | GO:0005667 |
| GeneOntologyCellularComponent | histone deacetylase complex | 8.29e-04 | 85 | 103 | 4 | GO:0000118 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.03e-03 | 90 | 103 | 4 | GO:0016328 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.21e-03 | 94 | 103 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | nuclear speck | 1.32e-03 | 431 | 103 | 8 | GO:0016607 | |
| GeneOntologyCellularComponent | ciliary membrane | 1.41e-03 | 98 | 103 | 4 | GO:0060170 | |
| HumanPheno | Aplasia/hypoplasia involving the skeleton | LRP12 IFT172 PEPD PEX1 HUWE1 TRRAP JMJD1C GATAD2B TGFB1 C2CD3 CHD5 MYPN POP1 FGFR3 STRA6 CPLANE1 SLC25A19 HTT SOS2 | 4.88e-06 | 1343 | 28 | 19 | HP:0009115 |
| HumanPheno | Preaxial foot polydactyly | 1.81e-05 | 30 | 28 | 4 | HP:0001841 | |
| HumanPheno | Micrognathia | PEPD PEX1 HUWE1 TRRAP JMJD1C GATAD2B C2CD3 CHD5 MYPN FGFR3 STRA6 CPLANE1 SLC25A19 SOS2 | 4.24e-05 | 843 | 28 | 14 | HP:0000347 |
| HumanPheno | Aplasia/Hypoplasia of the mandible | PEPD PEX1 HUWE1 TRRAP JMJD1C GATAD2B C2CD3 CHD5 MYPN FGFR3 STRA6 CPLANE1 SLC25A19 SOS2 | 4.35e-05 | 845 | 28 | 14 | HP:0009118 |
| HumanPheno | Abnormal mandible morphology | IFT172 PEPD PEX1 HUWE1 TRRAP JMJD1C GATAD2B TGFB1 C2CD3 CHD5 MYPN FGFR3 STRA6 CPLANE1 SLC25A19 SOS2 | 5.29e-05 | 1118 | 28 | 16 | HP:0000277 |
| HumanPheno | Aplasia/hypoplasia affecting bones of the axial skeleton | IFT172 PEPD PEX1 HUWE1 TRRAP JMJD1C GATAD2B C2CD3 CHD5 MYPN FGFR3 STRA6 CPLANE1 SLC25A19 SOS2 | 7.01e-05 | 1008 | 28 | 15 | HP:0009122 |
| HumanPheno | Abnormality of the jaws | IFT172 PEPD PEX1 HUWE1 TRRAP JMJD1C GATAD2B TGFB1 C2CD3 CHD5 MYPN FGFR3 STRA6 CPLANE1 SLC25A19 SOS2 | 1.01e-04 | 1175 | 28 | 16 | HP:0000209 |
| HumanPheno | Abnormal jaw morphology | IFT172 PEPD PEX1 HUWE1 TRRAP JMJD1C GATAD2B TGFB1 C2CD3 CHD5 MYPN FGFR3 STRA6 CPLANE1 SLC25A19 SOS2 | 1.02e-04 | 1176 | 28 | 16 | HP:0030791 |
| HumanPheno | Aplasia/Hypoplasia involving bones of the skull | PEPD PEX1 HUWE1 TRRAP JMJD1C GATAD2B C2CD3 CHD5 MYPN FGFR3 STRA6 CPLANE1 SLC25A19 SOS2 | 1.08e-04 | 915 | 28 | 14 | HP:0009116 |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 2.47e-06 | 17 | 82 | 4 | MP:0031047 | |
| MousePheno | embryo tissue necrosis | 3.44e-06 | 40 | 82 | 5 | MP:0013241 | |
| MousePheno | increased skeletal muscle triglyceride level | 6.10e-06 | 21 | 82 | 4 | MP:0031415 | |
| MousePheno | exencephaly | TRPM6 SUPT20HL1 SUPT20H IFT172 SUPT20HL2 C2CD3 FURIN SLC25A19 HTT | 7.80e-06 | 230 | 82 | 9 | MP:0000914 |
| MousePheno | abnormal left-right axis symmetry of the somites | 1.07e-05 | 8 | 82 | 3 | MP:0005224 | |
| MousePheno | decreased fatty acid oxidation | 1.07e-05 | 24 | 82 | 4 | MP:0014172 | |
| MousePheno | abnormal fatty acid oxidation | 1.55e-05 | 54 | 82 | 5 | MP:0010953 | |
| MousePheno | increased abdominal fat pad weight | 1.74e-05 | 27 | 82 | 4 | MP:0009286 | |
| MousePheno | failure of initiation of embryo turning | 1.85e-05 | 56 | 82 | 5 | MP:0004180 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 2.02e-05 | 28 | 82 | 4 | MP:0020950 | |
| MousePheno | abnormal germ layer development | 2.12e-05 | 144 | 82 | 7 | MP:0001674 | |
| MousePheno | abnormal glycogen homeostasis | 2.12e-05 | 144 | 82 | 7 | MP:0005438 | |
| MousePheno | abnormal gastrulation movements | 2.27e-05 | 10 | 82 | 3 | MP:0002174 | |
| MousePheno | abnormal lipid oxidation | 2.82e-05 | 61 | 82 | 5 | MP:0010951 | |
| MousePheno | abnormal colon morphology | 3.01e-05 | 152 | 82 | 7 | MP:0000495 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 3.07e-05 | 31 | 82 | 4 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 3.07e-05 | 31 | 82 | 4 | MP:0008964 | |
| MousePheno | abnormal prenatal growth/weight/body size | TRPM6 SUPT20HL1 BCL9L LRP12 SUPT20H IFT172 PEPD SAV1 SUPT20HL2 HUWE1 RYR2 TGFB1 C2CD3 PTPN12 PELO FURIN CPLANE1 SLC25A19 GCN1 CLEC16A HTT NPAT | 3.32e-05 | 1493 | 82 | 22 | MP:0004196 |
| MousePheno | failure of chorioallantoic fusion | 4.46e-05 | 67 | 82 | 5 | MP:0009657 | |
| MousePheno | abnormal left-right axis patterning | 4.46e-05 | 67 | 82 | 5 | MP:0001706 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 5.01e-05 | 35 | 82 | 4 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 5.62e-05 | 36 | 82 | 4 | MP:0031412 | |
| MousePheno | decreased muscle cell glucose uptake | 7.74e-05 | 39 | 82 | 4 | MP:0030022 | |
| MousePheno | increased circulating leptin level | 9.11e-05 | 125 | 82 | 6 | MP:0005669 | |
| MousePheno | abnormal nervous system development | TRPM6 CACNA1A SUPT20HL1 SUPT20H IFT172 ARHGEF5 NR4A2 HIPK2 SUPT20HL2 GATAD2B TGFB1 GDPD5 C2CD3 PTPN12 FURIN STRA6 SLC25A19 GCN1 HTT | 9.38e-05 | 1257 | 82 | 19 | MP:0003861 |
| MousePheno | phlebitis | 1.02e-04 | 3 | 82 | 2 | MP:0010140 | |
| MousePheno | polyphagia | 1.05e-04 | 80 | 82 | 5 | MP:0001433 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 1.25e-04 | 44 | 82 | 4 | MP:0031023 | |
| MousePheno | abnormal embryonic growth/weight/body size | SUPT20HL1 BCL9L LRP12 SUPT20H IFT172 PEPD SUPT20HL2 HUWE1 RYR2 TGFB1 C2CD3 PTPN12 PELO FURIN CPLANE1 SLC25A19 GCN1 CLEC16A HTT | 1.39e-04 | 1295 | 82 | 19 | MP:0002088 |
| MousePheno | prenatal growth retardation | SUPT20HL1 SUPT20H IFT172 PEPD SAV1 SUPT20HL2 HUWE1 RYR2 TGFB1 C2CD3 PTPN12 PELO CPLANE1 GCN1 NPAT | 1.40e-04 | 869 | 82 | 15 | MP:0010865 |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 1.62e-04 | 47 | 82 | 4 | MP:0031617 | |
| MousePheno | abnormal chorioallantoic fusion | 1.83e-04 | 90 | 82 | 5 | MP:0002824 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 1.91e-04 | 49 | 82 | 4 | MP:0020948 | |
| MousePheno | abnormal large intestine morphology | 2.10e-04 | 276 | 82 | 8 | MP:0000489 | |
| MousePheno | increased circulating insulin level | 2.49e-04 | 283 | 82 | 8 | MP:0002079 | |
| MousePheno | decreased cellular glucose uptake | 2.59e-04 | 53 | 82 | 4 | MP:0003926 | |
| MousePheno | abnormal embryo development | SUPT20HL1 BCL9L SUPT20H IFT172 NOC3L PEPD SUPT20HL2 HUWE1 RYR2 TGFB1 C2CD3 PTPN12 PELO FURIN CPLANE1 SLC25A19 GCN1 HTT NPAT | 2.89e-04 | 1370 | 82 | 19 | MP:0001672 |
| MousePheno | abnormal heart development | 3.21e-04 | 372 | 82 | 9 | MP:0000267 | |
| MousePheno | abnormal cellular glucose uptake | 3.28e-04 | 102 | 82 | 5 | MP:0003925 | |
| MousePheno | increased taurine level | 3.36e-04 | 5 | 82 | 2 | MP:0030635 | |
| MousePheno | abnormal tegmentum morphology | 3.36e-04 | 5 | 82 | 2 | MP:0006100 | |
| MousePheno | open neural tube | 3.58e-04 | 226 | 82 | 7 | MP:0000929 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 4.18e-04 | 60 | 82 | 4 | MP:0009790 | |
| MousePheno | abnormal circulating leptin level | 4.64e-04 | 236 | 82 | 7 | MP:0005667 | |
| MousePheno | abnormal visceral yolk sac morphology | 4.64e-04 | 236 | 82 | 7 | MP:0001718 | |
| MousePheno | decreased respiratory quotient | 4.64e-04 | 110 | 82 | 5 | MP:0010379 | |
| MousePheno | embryonic growth retardation | SUPT20HL1 SUPT20H IFT172 PEPD SUPT20HL2 HUWE1 RYR2 TGFB1 C2CD3 PTPN12 PELO CPLANE1 GCN1 | 4.67e-04 | 763 | 82 | 13 | MP:0003984 |
| MousePheno | wavy tail | 5.02e-04 | 6 | 82 | 2 | MP:0013179 | |
| MousePheno | abnormal allantois morphology | 5.04e-04 | 112 | 82 | 5 | MP:0001726 | |
| MousePheno | increased insulin secretion | 5.35e-04 | 64 | 82 | 4 | MP:0003058 | |
| MousePheno | abnormal glucose tolerance | PSG2 PSG4 PSG6 RBL1 RBM4B RBM4 EPM2AIP1 TGFB1 BNIP3 GUCY2C PSG8 STRA6 ACOXL | 6.25e-04 | 787 | 82 | 13 | MP:0005291 |
| MousePheno | abnormal muscle cell glucose uptake | 6.37e-04 | 67 | 82 | 4 | MP:0004130 | |
| MousePheno | abnormal carbon dioxide production | 6.37e-04 | 67 | 82 | 4 | MP:0008962 | |
| MousePheno | abnormal neural tube morphology | TRPM6 SUPT20HL1 SUPT20H IFT172 HIPK2 SUPT20HL2 TGFB1 C2CD3 PTPN12 FURIN SLC25A19 | 6.44e-04 | 591 | 82 | 11 | MP:0002151 |
| MousePheno | abnormal embryo turning | 6.69e-04 | 251 | 82 | 7 | MP:0001700 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 6.91e-04 | 120 | 82 | 5 | MP:0009786 | |
| MousePheno | abnormal circulating insulin level | 7.18e-04 | 505 | 82 | 10 | MP:0001560 | |
| MousePheno | abnormal cardiovascular development | SUPT20HL1 SUPT20H IFT172 PEPD SUPT20HL2 RYR2 TGFB1 C2CD3 PTPN12 FURIN VGLL4 CPLANE1 NPAT | 7.46e-04 | 802 | 82 | 13 | MP:0002925 |
| MousePheno | increased food intake | 8.43e-04 | 189 | 82 | 6 | MP:0011939 | |
| MousePheno | abnormal vascular wound healing | 8.80e-04 | 73 | 82 | 4 | MP:0004883 | |
| MousePheno | abnormal mesoderm development | 9.26e-04 | 74 | 82 | 4 | MP:0001680 | |
| MousePheno | increased triglyceride level | 1.09e-03 | 354 | 82 | 8 | MP:0005317 | |
| MousePheno | abnormal primitive streak morphology | 1.16e-03 | 201 | 82 | 6 | MP:0002231 | |
| MousePheno | decreased oxygen consumption | 1.18e-03 | 79 | 82 | 4 | MP:0005290 | |
| MousePheno | retina cone cell degeneration | 1.21e-03 | 36 | 82 | 3 | MP:0008444 | |
| MousePheno | abnormal muscle physiology | CACNA1A PSG2 PSG4 PSG6 PDK2 RBL1 HIPK2 MLXIP RYR2 TGFB1 BNIP3 MYPN PSG8 VGLL4 | 1.21e-03 | 954 | 82 | 14 | MP:0002106 |
| MousePheno | abnormal intestine morphology | 1.30e-03 | 546 | 82 | 10 | MP:0000477 | |
| MousePheno | decreased susceptibility to Riboviria infection | 1.36e-03 | 82 | 82 | 4 | MP:0020914 | |
| MousePheno | misaligned incisors | 1.48e-03 | 10 | 82 | 2 | MP:0030541 | |
| Domain | Spt20 | 2.84e-05 | 2 | 100 | 2 | IPR021950 | |
| Domain | Spt20 | 2.84e-05 | 2 | 100 | 2 | PF12090 | |
| Domain | NPIP | 5.19e-05 | 14 | 100 | 3 | IPR009443 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 1.00e-05 | 188 | 79 | 8 | MM15828 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 9.00e-05 | 16 | 79 | 3 | M47373 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 24220028 | ||
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 5.28e-08 | 13 | 104 | 4 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 5.28e-08 | 13 | 104 | 4 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 5.28e-08 | 13 | 104 | 4 | 16638824 | |
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 20044046 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 32150576 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 6265583 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 5.28e-08 | 13 | 104 | 4 | 12832451 | |
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 5.28e-08 | 13 | 104 | 4 | 21670291 | |
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 22162753 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 2702644 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 8380065 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 1279194 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 25724769 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 5.28e-08 | 13 | 104 | 4 | 22092845 | |
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 11801635 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 5.28e-08 | 13 | 104 | 4 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 5.28e-08 | 13 | 104 | 4 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 5.28e-08 | 13 | 104 | 4 | 23800882 | |
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 19285068 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 21760897 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 5.28e-08 | 13 | 104 | 4 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 5.28e-08 | 13 | 104 | 4 | 39168268 | |
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 8402684 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 16619040 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 5.28e-08 | 13 | 104 | 4 | 8209741 | |
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 5.28e-08 | 13 | 104 | 4 | 21949477 | |
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 26219866 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 2133556 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 32521208 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 19406938 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 5.28e-08 | 13 | 104 | 4 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 5.28e-08 | 13 | 104 | 4 | 19358828 | |
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 16680193 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 5.28e-08 | 13 | 104 | 4 | 34058224 | |
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 10964771 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 32169849 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 5.28e-08 | 13 | 104 | 4 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 5.28e-08 | 13 | 104 | 4 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 5.28e-08 | 13 | 104 | 4 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 5.28e-08 | 13 | 104 | 4 | 23935487 | |
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 15331748 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 5.28e-08 | 13 | 104 | 4 | 22406619 | |
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 5.28e-08 | 13 | 104 | 4 | 25972571 | |
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 19008452 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 5.28e-08 | 13 | 104 | 4 | 15220458 | |
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 18843289 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 15207636 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 21081647 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 11133662 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 11483763 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 2164599 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 29396368 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 18003729 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 5.28e-08 | 13 | 104 | 4 | 33352461 | |
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 38381498 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 20739537 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 5.28e-08 | 13 | 104 | 4 | 27695943 | |
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 20404914 | ||
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 5.28e-08 | 13 | 104 | 4 | 32027621 | |
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 5.28e-08 | 13 | 104 | 4 | 27777319 | |
| Pubmed | 5.28e-08 | 13 | 104 | 4 | 18848945 | ||
| Pubmed | Detailed comparative map of human chromosome 19q and related regions of the mouse genome. | 5.32e-08 | 67 | 104 | 6 | 8812484 | |
| Pubmed | 7.38e-08 | 14 | 104 | 4 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 7.38e-08 | 14 | 104 | 4 | 34666041 | |
| Pubmed | 7.38e-08 | 14 | 104 | 4 | 34619794 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 7.38e-08 | 14 | 104 | 4 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 7.38e-08 | 14 | 104 | 4 | 32209360 | |
| Pubmed | 7.38e-08 | 14 | 104 | 4 | 11994468 | ||
| Pubmed | 7.38e-08 | 14 | 104 | 4 | 11850617 | ||
| Pubmed | 7.38e-08 | 14 | 104 | 4 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 7.38e-08 | 14 | 104 | 4 | 26196244 | |
| Pubmed | 7.38e-08 | 14 | 104 | 4 | 8896983 | ||
| Pubmed | 7.38e-08 | 14 | 104 | 4 | 22962327 | ||
| Pubmed | 7.38e-08 | 14 | 104 | 4 | 17623671 | ||
| Pubmed | 7.38e-08 | 14 | 104 | 4 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 7.38e-08 | 14 | 104 | 4 | 18794798 | |
| Pubmed | 7.38e-08 | 14 | 104 | 4 | 23469261 | ||
| Pubmed | 7.38e-08 | 14 | 104 | 4 | 18454175 | ||
| Pubmed | 7.38e-08 | 14 | 104 | 4 | 22159884 | ||
| Pubmed | 7.38e-08 | 14 | 104 | 4 | 29907459 | ||
| Pubmed | 7.38e-08 | 14 | 104 | 4 | 36719377 | ||
| Pubmed | 7.38e-08 | 14 | 104 | 4 | 23780386 | ||
| Interaction | SORCS1 interactions | 4.09e-06 | 7 | 100 | 3 | int:SORCS1 | |
| Cytoband | 16p12.2 | 8.30e-05 | 37 | 104 | 3 | 16p12.2 | |
| Cytoband | 1q41 | 4.66e-04 | 66 | 104 | 3 | 1q41 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 6.53e-04 | 172 | 104 | 4 | chr16p12 | |
| Cytoband | Xp22.11 | 1.04e-03 | 21 | 104 | 2 | Xp22.11 | |
| Cytoband | 9p22 | 1.47e-03 | 25 | 104 | 2 | 9p22 | |
| Cytoband | 19p13 | 1.72e-03 | 27 | 104 | 2 | 19p13 | |
| Cytoband | 10q21.3 | 2.72e-03 | 34 | 104 | 2 | 10q21.3 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 4.93e-08 | 11 | 65 | 4 | 1315 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 2.99e-04 | 163 | 65 | 5 | 590 | |
| GeneFamily | Lysine acetyltransferases|ATAC complex|SAGA complex|GCN5 related N-acetyltransferases | 1.67e-03 | 17 | 65 | 2 | 1059 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 1.33e-06 | 48 | 104 | 5 | MM531 | |
| Coexpression | DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS | 5.55e-06 | 171 | 104 | 7 | M40134 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 7.72e-06 | 32 | 104 | 4 | MM2 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 1.11e-05 | 35 | 104 | 4 | MM757 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 1.24e-05 | 75 | 104 | 5 | MM605 | |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 9.47e-05 | 184 | 104 | 6 | M19988 | |
| Coexpression | GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN | 1.07e-04 | 188 | 104 | 6 | M8016 | |
| Coexpression | GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_UP | 1.20e-04 | 192 | 104 | 6 | M7558 | |
| Coexpression | GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_UP | 1.41e-04 | 198 | 104 | 6 | M8407 | |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | CACNA1A TCEA2 LRP12 RBM4B TENM2 EPM2AIP1 KIAA0319 CELSR2 ANKRD16 | 1.44e-04 | 488 | 104 | 9 | M39104 |
| Coexpression | GSE29949_MICROGLIA_VS_DC_BRAIN_UP | 1.45e-04 | 199 | 104 | 6 | M8399 | |
| Coexpression | GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN | 1.45e-04 | 199 | 104 | 6 | M8388 | |
| Coexpression | GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN | 1.49e-04 | 200 | 104 | 6 | M6411 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP | 1.49e-04 | 200 | 104 | 6 | M8030 | |
| Coexpression | HALLMARK_KRAS_SIGNALING_DN | 1.49e-04 | 200 | 104 | 6 | M5956 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH2_UP | 1.49e-04 | 200 | 104 | 6 | M5566 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SUPT20H NPIPB3 TRRAP C2CD3 PTPN12 OSBPL8 EIF3A KAZN CLEC16A DOP1B NPAT SOS2 | 1.50e-04 | 856 | 104 | 12 | M4500 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 1.60e-04 | 128 | 104 | 5 | MM1000 | |
| Disease | cD177 antigen measurement | 3.38e-07 | 18 | 98 | 4 | EFO_0021866 | |
| Disease | Multiple Myeloma | 1.16e-05 | 42 | 98 | 4 | C0026764 | |
| Disease | serum gamma-glutamyl transferase measurement | IFT172 NOC3L PEPD TENM2 JMJD1C RYR2 TGFB1 CELSR2 STKLD1 GCN1 ACOXL PROX1 | 5.12e-05 | 914 | 98 | 12 | EFO_0004532 |
| Disease | chronic myeloid leukemia (is_marker_for) | 9.81e-05 | 27 | 98 | 3 | DOID:8552 (is_marker_for) | |
| Disease | longevity, healthspan, parental longevity | 1.22e-04 | 29 | 98 | 3 | EFO_0004300, EFO_0007796, EFO_0009762 | |
| Disease | aspartate aminotransferase measurement | TCEA2 NOC3L PEPD TGFB1 MYPN KAZN STKLD1 GCN1 CLEC16A ACOXL SOS2 | 2.08e-04 | 904 | 98 | 11 | EFO_0004736 |
| Disease | pregnancy-specific beta-1-glycoprotein 3 measurement | 2.27e-04 | 7 | 98 | 2 | EFO_0801906 | |
| Disease | Colorectal Neoplasms | 3.31e-04 | 277 | 98 | 6 | C0009404 | |
| Disease | Thrombocytosis, Autosomal Dominant | 3.87e-04 | 9 | 98 | 2 | C3489628 | |
| Disease | Gastrointestinal Stromal Sarcoma | 5.18e-04 | 47 | 98 | 3 | C3179349 | |
| Disease | factor VIII measurement, coronary artery disease | 5.58e-04 | 113 | 98 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | Nephrosclerosis | 5.89e-04 | 11 | 98 | 2 | C0027719 | |
| Disease | Diarrhea | 5.89e-04 | 11 | 98 | 2 | C0011991 | |
| Disease | Gastrointestinal Stromal Tumors | 6.22e-04 | 50 | 98 | 3 | C0238198 | |
| Disease | Polydactyly | 6.36e-04 | 117 | 98 | 4 | C0152427 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 6.57e-04 | 118 | 98 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | free cholesterol in large LDL measurement | 6.59e-04 | 51 | 98 | 3 | EFO_0022176 | |
| Disease | Thrombocythemia, Essential | 7.05e-04 | 12 | 98 | 2 | C0040028 | |
| Disease | IGA glomerulonephritis | 9.60e-04 | 58 | 98 | 3 | EFO_0004194 | |
| Disease | Manganese Poisoning | 9.68e-04 | 14 | 98 | 2 | C0677050 | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 9.68e-04 | 14 | 98 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | CD209 antigen measurement | 9.68e-04 | 14 | 98 | 2 | EFO_0008077 | |
| Disease | Saldino-Noonan Syndrome | 9.68e-04 | 14 | 98 | 2 | C0036069 | |
| Disease | Hypertriglyceridemia | 1.11e-03 | 15 | 98 | 2 | C0020557 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 1.22e-03 | 63 | 98 | 3 | EFO_0001645, EFO_0004792 | |
| Disease | Drugs used in diabetes use measurement | 1.64e-03 | 255 | 98 | 5 | EFO_0009924 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 1.72e-03 | 71 | 98 | 3 | EFO_0001645, EFO_0004791 | |
| Disease | fibrinogen measurement, coronary artery disease | 1.76e-03 | 154 | 98 | 4 | EFO_0001645, EFO_0004623 | |
| Disease | Dermatologic disorders | 2.02e-03 | 75 | 98 | 3 | C0037274 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 2.20e-03 | 21 | 98 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | Hepatitis, Chronic | 2.42e-03 | 22 | 98 | 2 | C0019189 | |
| Disease | Chronic active hepatitis | 2.42e-03 | 22 | 98 | 2 | C0520463 | |
| Disease | Chronic Persistent Hepatitis | 2.42e-03 | 22 | 98 | 2 | C0149519 | |
| Disease | e-selectin measurement | 2.42e-03 | 22 | 98 | 2 | EFO_0004575 | |
| Disease | Cryptogenic Chronic Hepatitis | 2.42e-03 | 22 | 98 | 2 | C0524611 | |
| Disease | Septicemia | 2.87e-03 | 24 | 98 | 2 | C0036690 | |
| Disease | Sepsis | 2.87e-03 | 24 | 98 | 2 | C0243026 | |
| Disease | Severe Sepsis | 2.87e-03 | 24 | 98 | 2 | C1719672 | |
| Disease | Ureteral obstruction | 2.87e-03 | 24 | 98 | 2 | C0041956 | |
| Disease | Pyemia | 2.87e-03 | 24 | 98 | 2 | C0034189 | |
| Disease | liver fibrosis measurement | 2.98e-03 | 86 | 98 | 3 | EFO_0010576 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKRMIATVPLRHSIR | 16 | A8MVM7 | |
| SSMFILSTTNPLRRL | 1221 | O00555 | |
| TESKIRRTPLHTAAM | 166 | Q6P6B7 | |
| SRQHVLTRIGVMSLV | 1496 | Q8TDI0 | |
| IPVVRNSTVLLSMTH | 1156 | Q12774 | |
| MPRRSALATLTILVT | 266 | Q9HCU4 | |
| PTIHNRTFSRLMNLT | 66 | Q99467 | |
| QTQTLRLMPHLATAL | 281 | Q9NUZ1 | |
| RMIISRHLPSVSSLP | 581 | Q92617 | |
| QQMIISRHLPSVSSL | 706 | Q92617 | |
| MHVQLSTSRLRTAPG | 141 | Q9BWF3 | |
| SLRTARHLQPGMVLT | 396 | P12955 | |
| SRMESTGLPLRIHVS | 951 | P25092 | |
| PQRMIISRHLPSVSS | 541 | F8W0I5 | |
| QRMIISRHLPSVSSL | 626 | F8W0I5 | |
| HTLSQIRSMQSSPRF | 91 | Q14207 | |
| HQVLIRRTGIPISMS | 291 | O94952 | |
| STMTQRLPHSEITTL | 7356 | Q8WXI7 | |
| HLPSVSITSLLRQLM | 646 | Q86TB9 | |
| MDLTRHSGTISQPRI | 1261 | Q14667 | |
| RLQQVELVRTTPMSH | 431 | Q674X7 | |
| PHNLMRRSTVSLLDT | 111 | Q9H2X6 | |
| PARHQLTSALSRMTQ | 721 | Q9Y561 | |
| LLRQHSVSSIRQLMP | 2231 | Q9Y3R5 | |
| VSSTNTLRSMPALHR | 1191 | Q15652 | |
| LPQTHSLSNRRTLMI | 26 | P01569 | |
| MTSRLLQLPDKHSVT | 756 | Q96RN5 | |
| QPMIISRHLPSVSSL | 621 | A8MRT5 | |
| QMIISRHLPSVSSLP | 706 | A8MRT5 | |
| PQRMIISRHLPSVSS | 746 | A8MRT5 | |
| QRMIISRHLPSVSSL | 831 | A8MRT5 | |
| PFLMHDTTLRRTTNV | 271 | Q8WTR4 | |
| FITRHLDQIIPRMTT | 701 | Q92616 | |
| SVIRSATNTTLPHML | 246 | Q8WXI9 | |
| MSLQRIVRVSLEHPT | 1 | Q9ULW8 | |
| QRMIISRHLPSVSSL | 626 | C9JG80 | |
| RMIISRHLPSVSSLP | 711 | C9JG80 | |
| PQRMIISRHLPSVSS | 751 | C9JG80 | |
| QRMIISRHLPSVSSL | 836 | C9JG80 | |
| MHVQLSTSRLRTAPG | 141 | Q9BQ04 | |
| NMLSHPVIRRSSLLT | 3436 | Q7Z6Z7 | |
| SRISIRMLINQHTLI | 161 | Q15119 | |
| VRTEFMNPHLISVRI | 431 | Q9UG01 | |
| QRMIISRHLPSVSSL | 636 | E5RHQ5 | |
| QPMIISRHLPSVSSL | 846 | E5RHQ5 | |
| RNIMALRNHLVSSTP | 846 | Q9BZF1 | |
| SSNSLVFQTLPRHMR | 126 | Q99575 | |
| ILRPMVLSTLRQLST | 876 | Q9HAP2 | |
| PLQRIRSTSTPNVHM | 206 | P10398 | |
| SLPSRTHLRAMGTLR | 31 | Q8WWV6 | |
| DSLNLRARSMITTHP | 1816 | P42858 | |
| RARSMITTHPALVLL | 1821 | P42858 | |
| LIVPMHTRRSRVSLV | 506 | O94889 | |
| HPKRTATLSMRNTSV | 136 | Q12983 | |
| LPLSRICAMVTTQHR | 1131 | Q4AC94 | |
| PSVHMRSLLLDSTQR | 431 | Q9H799 | |
| QRMSTRVLLATLSIP | 316 | Q14152 | |
| LSLQRMVGLTTTHTL | 236 | Q7L775 | |
| STLMRTVHSVIKRTP | 221 | Q86SF2 | |
| LAIHLVSPMGTRSTL | 501 | P09958 | |
| SHPLRQRSVSLDSQM | 1471 | Q86UU0 | |
| RTRLRLQTMTLEHVL | 36 | P48664 | |
| TTITNRTMRLLPRHF | 281 | Q8NEE6 | |
| HMVTARQEPRLVLIS | 101 | Q969Z3 | |
| LPQTHSLGSRRTLML | 26 | P01563 | |
| FTQLHSTMTRAPLLL | 11 | Q6UXQ4 | |
| RRIYLQMTTLQPHLS | 551 | Q96AY2 | |
| MSSNTPLVRIARLSS | 431 | P22607 | |
| VVLTTSPSQPHRRMS | 716 | O95479 | |
| SLPMTHRLQLSKTNR | 186 | Q00888 | |
| TRLVNHVSSMRPNIF | 646 | Q92736 | |
| THSLLGRPLSRQLMS | 571 | O43933 | |
| LAAIPVTHSLSLSRM | 886 | Q5VVW2 | |
| QPMIISRHLPSVSSL | 626 | A6NJU9 | |
| RMIISRHLPSVSSLP | 711 | A6NJU9 | |
| SSIGILATTRILMHT | 641 | Q8WTT2 | |
| RTHSRIMILSQGLQT | 336 | P03905 | |
| HMIEQRKTPVSRLSL | 161 | P43354 | |
| SPEQLSGIRMIRHLT | 1251 | Q5JY77 | |
| TLVTLPRSHSMRFID | 2671 | O75445 | |
| MTASVLRSISLALRP | 1 | Q9NQ50 | |
| MKRLSLVTTNRLSPH | 1 | O75677 | |
| SPNLLKMIRHTTNLT | 816 | Q07890 | |
| QSRHILLRPTMQTLA | 161 | Q3ZLR7 | |
| DHLSRQRDTTMSPLL | 306 | B4DYI2 | |
| LLRHVMNPLETLSIT | 316 | P78395 | |
| SLLTLNHMGRRISQI | 396 | Q8N4F4 | |
| ISTNRLLTLPERLHM | 141 | Q86X40 | |
| SLRRDMQPLSPISVH | 631 | P28749 | |
| LPMTHRLQLSKTNRT | 186 | Q00889 | |
| SLPMSHRLQLSETNR | 186 | Q9UQ74 | |
| NIIRGMSHSPSVALR | 171 | Q92786 | |
| STRKVLPMSIARHNI | 641 | Q05209 | |
| TMTQSTVPLNLIRVH | 1086 | Q9NT68 | |
| LAHICLVTPSMTLTR | 146 | Q9BRX2 | |
| VVSRMAALRTQTLPS | 46 | Q9H6W3 | |
| LTFLVLMRSLVTHRT | 376 | Q9BX79 | |
| QSRHILLRPTMQTLA | 161 | P0C7V6 | |
| SSLTVHPILRLIITM | 106 | Q8TAZ6 | |
| HPESMVRIAVRTITL | 181 | Q2KHT3 | |
| RMQTLPVASALSSHR | 31 | Q14135 | |
| TSPLLRNLMPSFIRH | 26 | Q9H4B6 | |
| VFMHRRTSLKSPITV | 151 | Q8NEP9 | |
| LRPFVSHTCTQMLLT | 716 | Q9BX84 | |
| VSLTLHRQMVPASIT | 306 | Q8NE28 | |
| MATPLERAQHLQSSR | 261 | P01137 | |
| SRHILLRPTMQTLIC | 161 | Q8NEM7 | |
| TLISTPHIRSMANQL | 601 | Q8WWQ8 | |
| QVLSRLSTLKSHMRT | 541 | Q96JL9 | |
| SHRMNLPVASQLIIS | 141 | Q5TYW1 | |
| ITTALNTLNRMVHSP | 301 | Q8TEC5 | |
| AMPITLHLLQSTRVG | 36 | Q15560 | |
| SLPMTHRFQLSETNR | 186 | P11465 | |
| LITMQSHVIRLPTGA | 221 | Q12789 | |
| MATLTVHPVDVLRTR | 131 | Q9HC21 | |
| AVHSLLSRLMSIFPT | 2211 | Q9Y4A5 | |
| ISPNLETTRIMRVSH | 36 | Q5VV43 | |
| SGHLMVQSLPIRSRL | 1031 | Q86TC9 |